Assay Report
Methods · Standard Curves · QC · Results
Measure macrophage polarization (M1 pro-inflammatory, M2 anti-inflammatory) and interferon subtypes (Type I/II/III) using MSD pre-configured U-PLEX Macrophage Combo panels and custom interferon configurations — all on one electrochemiluminescence platform from 25 µL serum, plasma, or cell culture supernatant.
M1 Macrophages (9-plex): IL-1β, IL-6, IL-12p70, IL-18, IL-23, IP-10, MCP-1, MIP-1α, TNF-α — the classical pro-inflammatory polarization panel. M2 Macrophages (7-plex): IL-4, IL-10, IL-13, M-CSF, MDC, TARC, Eotaxin-2 — the alternative/anti-inflammatory panel. Type I Interferons: IFN-α2a, IFN-β. Type II: IFN-γ — the canonical M1-polarizing cytokine. Type III: IFN-λ1/IL-29, IFN-λ2/IL-28A. MSD U-PLEX measures M1, M2, and IFN markers simultaneously — providing the integrated myeloid-cytokine activation profile from a single 25 µL sample per panel.
| Panel | Plex | Key Biomarkers | Species | Configuration |
|---|---|---|---|---|
| U-PLEX Macrophage M1 Combo 1 | 9 | IL-1β, IL-6, IL-12p70, IL-18, IL-23, IP-10, MCP-1, MIP-1α, TNF-α | Human | Pre-configured |
| U-PLEX Macrophage M2 Combo 1 | 7 | Eotaxin-2, IL-4, IL-10, IL-13, M-CSF, MDC, TARC | Human | Pre-configured |
| Custom Type I/II/III IFN Panel | 2–6 | IFN-α2a, IFN-β, IFN-γ, IFN-λ1 (IL-29), IFN-λ2 (IL-28A), IP-10 | Human, Mouse | U-PLEX Custom |
| Mouse Macrophage 5-Plex (M2) | 5 | IL-10, IL-13, IL-4, MDC, TARC | Mouse | Available |
| Mouse Macrophage 9-Plex (M1) | 9 | IL-15, IL-23, IL-6, TNF-α, IL-1β, IL-12p70, IP-10, MCP-1, MIP-1α | Mouse | Available |
| Mouse IFN 3-Plex / Human IFN 4-Plex | 3–4 | IFN-α, IFN-β, IFN-γ (± IFN-λ1) | Human, Mouse | Available |
M1 and M2 Combo panels are pre-configured U-PLEX products with validated antibody pairs. M1 (25 µL) + M2 (25 µL) + IFN custom (25 µL) = 75 µL total. All services are for research use only.
Platform comparison for macrophage profiling
MSD U-PLEX offers the only pre-configured M1/M2 macrophage panels. For research use only.
| Item | Full Service | Notes |
|---|---|---|
| M1 Panel (9-plex) | Pre-configured | IL-1β, IL-6, IL-12p70, IL-18, IL-23, IP-10, MCP-1, MIP-1α, TNF-α |
| M2 Panel (7-plex) | Pre-configured | IL-4, IL-10, IL-13, M-CSF, MDC, TARC, Eotaxin-2 |
| IFN Custom Panel | Custom build | Select IFN-α, IFN-β, IFN-γ, IFN-λ1/2, IP-10 |
| Standard Curves | Per-analyte calibrators | Recombinant standards per panel |
| Data Report | Excel + PDF | M1/M2 ratios, IFN subtype data |
For Research Use Only. Not for diagnostic procedures.
Typical workflow for generating M1/M2 macrophages from monocytes and tracking polarization with MSD U-PLEX panels.
Day 0–6: M-CSF (50 ng/mL) → M0 macrophages. Collect supernatant at Day 3, 6 for baseline M0 cytokine profile.
Day 6: IFN-γ (20 ng/mL) + LPS (100 ng/mL) → M1. IL-4 (20 ng/mL) + IL-13 (20 ng/mL) → M2. Keep M0 control well.
Collect supernatant at 6h, 24h, 48h post-polarization. 25 µL per panel/timepoint for M1, M2, and IFN.
Always include M0 baseline. M1/M2 ratios normalized to M0 are more reproducible. For research use only.
| Feature | MSD U-PLEX | Luminex xMAP | Single-Analyte ELISA |
|---|---|---|---|
| Dedicated M1/M2 Panels | Yes — pre-configured M1 (9-plex) + M2 (7-plex) | No dedicated macrophage panel | N/A — one analyte per well |
| M1/M2 Ratio Precision | Within-well — superior ratio accuracy | Cross-bead — CV degrades ratio | Cross-well — worst ratio precision |
| Custom IFN Add-On | Yes — add IFN-α/β/γ/λ to same platform | Yes — from cytokine menu | Separate kits required |
| Sample (M1+M2+IFN) | 75 µL total (3 panels) | ~75 µL (single higher-plex) | >1.5 mL for equivalent coverage |
| Cell Supernatant Compatibility | Low matrix interference | Moderate — serum matrix effects | Variable — kit-dependent |
The pre-configured M1 (9-plex) and M2 (7-plex) Combos are validated with optimized antibody pairs. For standard macrophage polarization research, the Combos provide core markers with zero development time. Use custom U-PLEX for combining M1+M2 markers into one well, adding non-standard markers, or including interferon subtypes. For research use only.
Macrophage polarization exists along a continuum. TNF-α/IL-10 reflects pro- vs. anti-inflammatory balance. IL-12/IL-10 captures Th1-polarizing capacity. IL-6/IL-10 indicates acute-phase vs. anti-inflammatory. MCP-1/MDC reflects M1 vs. M2 chemotactic signature. MSD within-well measurement provides superior ratio precision. For research use only.
IFN-γ is the canonical M1-polarizing cytokine. Type I IFNs are produced by macrophages upon viral sensing. Type III IFNs act on mucosal myeloid cells. Measuring interferons and macrophage markers together captures both regulatory signals and functional output from the same sample. For research use only.
Yes. TAMs display M2-skewed phenotype that promotes tumor growth. The panels measure M2→M1 repolarization after anti-CSF-1R, CD40 agonist, or STING agonist treatment. Applicable to in vitro models, drug response biomarkers, tumor tissue homogenates, and in vivo mouse models. For research use only.
Cell culture supernatant: centrifuge 300×g 5min, aliquot immediately. EDTA plasma preferred for in vivo samples. Store at -80°C. Include M0 baseline and M1 (IFN-γ+LPS) and M2 (IL-4+IL-13) positive controls. Type I IFNs peak at 2-6h post-stimulation. For research use only.
Demo Assay Report
Request a representative report to review how assay methods, standard curves, quality-control metrics, and quantitative results are presented.
Online Inquiry
×